[The Need for Lens Radiation Protection for Healthcare Provider in Open and Internal Fixation of the Hip Joint].

Autor: Matsumoto H; Department of Radiological Technology, Kawasaki Medical School Hospital., Tokushige S; Department of Radiological Technology, Kawasaki Medical School Hospital., Takei Y; Department of Radiological Technology, Kawasaki University of Medical Welfare., Uyama Y; Department of Radiological Technology, Kawasaki Medical School Hospital., Mura M; Department of Radiological Technology, Kawasaki Medical School Hospital., Hitomi G; Department of Radiological Technology, Kawasaki Medical School Hospital.

Publikováno v: Nihon Hoshasen Gijutsu Gakkai zasshi [Nihon Hoshasen Gijutsu Gakkai Zasshi] 2024 Mar 20; Vol. 80 (3), pp. 287-295. Date of Electronic Publication: 2024 Jan 30.

Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on Neutrophil-Lymphocyte Ratio Fluctuation and Liver Metastases.

Autor: Nishio K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan, kyousuke.nishio@ompu.ac.jp., Higashio T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Komura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Fukuokaya W; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Adachi T; Department of Urology, Tokyo Medical University, Tokyo, Japan., Hirasawa Y; Department of Urology, Tokyo Medical University, Tokyo, Japan., Hashimoto T; Department of Urology, Tokyo Medical University, Tokyo, Japan., Yoshizawa A; Department of Urology, Fujita-Health University School of Medi Dengakugakubo, Toyoake, Japan., Tsuchida S; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Matsuda T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Nishimura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Tokushige S; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Nakamori K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Uchimoto T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Yamamoto S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Mori K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tsuduki S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Takahara K; Department of Urology, Fujita-Health University School of Medi Dengakugakubo, Toyoake, Japan., Inamoto T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Miki J; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Ohno Y; Department of Urology, Tokyo Medical University, Tokyo, Japan., Shiroki R; Department of Urology, Fujita-Health University School of Medi Dengakugakubo, Toyoake, Japan., Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan.

Publikováno v: Oncology [Oncology] 2024; Vol. 102 (6), pp. 457-464. Date of Electronic Publication: 2023 Oct 13.

Tertiary lymphoid structure and neutrophil-lymphocyte ratio coordinately predict outcome of pembrolizumab.

Autor: Komura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.; Division of Translational Research, Osaka Medical and Pharmaceutical, Takatsuki City, Osaka, Japan., Tokushige S; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Ishida M; Department of Pathology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Hirosuna K; Graduate School of Medicine, Okayama University, Okayama, Japan., Yamazaki S; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Nishimura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Ajiro M; Division of Cancer RNA Research, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Ohno T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Nakamori K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Kinoshita S; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Maenosono R; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Yoshikawa Y; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Takai T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Tsutsumi T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Taniguchi K; Division of Translational Research, Osaka Medical and Pharmaceutical, Takatsuki City, Osaka, Japan., Tanaka T; Division of Translational Research, Osaka Medical and Pharmaceutical, Takatsuki City, Osaka, Japan., Takahara K; Department of Urology, Fujita-Health University School of Medicine, Toyoake City, Japan., Inamoto T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Hirose Y; Department of Pathology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan., Ono F; Division of Translational Research, Osaka Medical and Pharmaceutical, Takatsuki City, Osaka, Japan., Shiraishi Y; Division of Genome Analysis Platform Development, National Cancer Center Research, Chuo-ku, Tokyo, Japan., Yoshimi A; Division of Cancer RNA Research, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.

Publikováno v: Cancer science [Cancer Sci] 2023 Dec; Vol. 114 (12), pp. 4622-4631. Date of Electronic Publication: 2023 Sep 26.

The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.

Autor: Komura K; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan. kazumasa.komura@ompu.ac.jp.; Division of Translational Research, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan. kazumasa.komura@ompu.ac.jp., Hirosuna K; Division of Translational Research, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan.; Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-Cho Kitaku, Okayama City, Okayama, 700-8558, Japan., Tokushige S; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Nishimura K; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Ishida M; Department of Pathology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Hayashi T; Department of Human Pathology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Ura A; Department of Human Pathology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Ohno T; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Yamazaki S; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Nakamori K; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Kinoshita S; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Maenosono R; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Ajiro M; Division of Cancer RNA Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Yoshikawa Y; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Takai T; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Tsutsumi T; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Taniguchi K; Division of Translational Research, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Tanaka T; Division of Translational Research, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Takahara K; Department of Urology, Fujita-Health University School of Medicine, Toyoake City, 1-98 Dengakugakubo, KutsukakeAichi, 470-1192, Japan., Konuma T; Graduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-Cho, Tsurumiku-Ku, Yokohama, Kanagawa, 230-0045, Japan., Inamoto T; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Hirose Y; Department of Pathology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Ono F; Division of Translational Research, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan., Shiraishi Y; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Yoshimi A; Division of Cancer RNA Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. ayoshimi@ncc.go.jp., Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki City, Osaka, 569-8686, Japan.

Publikováno v: Molecular cancer [Mol Cancer] 2023 Nov 18; Vol. 22 (1), pp. 185. Date of Electronic Publication: 2023 Nov 18.

COVID-19 Complicated With Severe Systemic Capillary Leak Syndrome in an Infant.

Autor: Tokushige S; Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan., Ueno K, Morimoto M, Shimozono T, Nakamura A, Nakazaki N, Nakagawa S, Okamoto Y

Publikováno v: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2023 Feb 01; Vol. 42 (2), pp. e58-e60. Date of Electronic Publication: 2022 Nov 09.